Puma Biotechnology, Inc. Gains 37.67%

Wed, Feb 05, 2020 at 05:30 PM

Puma Biotechnology, Inc. (PBYI:NASDAQ) shot up at $14.57, a gain of 37.7%. On Tue 04 Feb 20, PBYI:NASDAQ touched a New 2-Week High of $10.58. The stock got featured on our News Catalysts scanner on Tue 21 Jan 20 at 05:38 PM in the 'BIOTECH' category. From Tue 14 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days

About Puma Biotechnology, Inc. (PBYI:NASDAQ)

Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.

Top 10 Gainers:

SenesTech, Inc. (SNES:NASDAQ), 1854.44%
Myomo, Inc. (MYO:NYSEMKT), 88.61%
VIVUS, Inc. (VVUS:NASDAQ), 46.96%
Puma Biotechnology, Inc. (PBYI:NASDAQ), 37.67%
Huitao Technology Co., Ltd. (HHT:NASDAQ), 34.61%
Wah Fu Education Group Limited (WAFU:NASDAQ), 34.24%
Greenhill & Co., Inc. (GHL:NYSE), 29.15%
FTS International, Inc. (FTSI:NYSE), 29.11%
CONSOL Energy Inc. (CEIX:NYSE), 26.59%
Peabody Energy Corporation (BTU:NYSE), 25.64%